XTX-301
xilio therapeutics
['xilio']
the fda has cleared our ind for our tumor-activated il-12, xtx301, in solid tumors. our il-12 has the potential to shift the #cancer #immunotherapy landscape and provide a significant impact to patient outcomes. #sitc22